pazopanib and Spinal-Neoplasms

pazopanib has been researched along with Spinal-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for pazopanib and Spinal-Neoplasms

Article	Year
[A Case of Chordoma of the Sacrum Treated with Pazopanib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:2 A-70-year-old man with chordoma of the sacrum was treated with pazopanib (initially 400 mg/day, upto 800 mg/day). After 2 months of treatment, a significant tumor reduction was achieved and the patient was able to sit down easily. Therefore, the pazopanib therapy was continued. He had 14 months of progression-free survival. Topics: Aged; Angiogenesis Inhibitors; Biopsy; Chordoma; Humans; Indazoles; Male; Pyrimidines; Quality of Life; Sacrum; Spinal Neoplasms; Sulfonamides	2016
What next? Choosing second-line therapy in progressive renal cell carcinoma. Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:9 Topics: Aged; Angiogenesis Inhibitors; Axitinib; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Prognosis; Pyrimidines; Radiography; Spinal Neoplasms; Sulfonamides	2014

Article

Year

[A Case of Chordoma of the Sacrum Treated with Pazopanib].

Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:2

A-70-year-old man with chordoma of the sacrum was treated with pazopanib (initially 400 mg/day, upto 800 mg/day). After 2 months of treatment, a significant tumor reduction was achieved and the patient was able to sit down easily. Therefore, the pazopanib therapy was continued. He had 14 months of progression-free survival.

Topics: Aged; Angiogenesis Inhibitors; Biopsy; Chordoma; Humans; Indazoles; Male; Pyrimidines; Quality of Life; Sacrum; Spinal Neoplasms; Sulfonamides

2016

What next? Choosing second-line therapy in progressive renal cell carcinoma.

Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:9

Topics: Aged; Angiogenesis Inhibitors; Axitinib; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Prognosis; Pyrimidines; Radiography; Spinal Neoplasms; Sulfonamides

2014